Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/27/21 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 07/27/21 | Initial statement of beneficial ownership of securities |
|
2 | ||
| 06/21/21 | Prospectus filed pursuant to Rule 424(b)(5) |
|
50 | ||
| 06/21/21 | Current report filing |
|
4 | ||
| 06/17/21 | Current report filing |
|
2 | ||
| 06/16/21 | Notice of Effectiveness |
|
1 | ||
| 06/15/21 | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | ||
| 06/15/21 | Registration statement for specified transactions by certain issuers |
|
47 | ||
| 06/14/21 | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | ||
| 05/14/21 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
52 |